The only update for patients with stage IV NSCLC without driver alterations is that patients who have HER2-overexpressing (IHC 3+) disease and good performance status can receive trastuzumab ...

Dr. Yifan Jian explores the evolution of OCT, challenges in retinal imaging, and AI's potential in biophotonics, shaping the ...

Maintain your privacy wherever you are with Windows 11 security features that help protect what matters to you across your devices. Windows 11 PCs deliver layers of security to help keep bad actors at ...